Sutro Biopharma Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Sutro Biopharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014055
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sutro Biopharma Inc (Sutro), formerly Fundamental Applied Biology Inc, discovers and develops antibody drug conjugate and multi-specific antibody-based therapeutics. The company develops its pipeline products through Xpress CF platform, a biochemical protein synthesis system, for the treatment of cancer therapy, including immuno-oncology therapies. Sutro has its manufacturing facility in San Carlos, California. In addition to development of its own drug candidate pipeline, Sutro also has collaboration with various pharmaceutical and biotech companies, for discovery and development of novel therapeutics. Sutro is headquartered in San Francisco, California, the US.

Sutro Biopharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sutro Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
SutroVax Raises Funds Through Initial Financing Round 10
Sutro Biopharma Raises US$26 Million In Series D Financing 11
Sutro Biopharma Raises US$16.5 Million In Second Tranche Of Series C Financing 13
Partnerships 14
Sutro Biopharma Amends Co-Development Agreement with Celgene 14
Sutro Biopharma Enters into Agreement with University of California, San Francisco 16
Sutro Biopharma Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 17
Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 18
Sutro Biopharma Enters Into Co-Development Agreement With Celgene 19
Sutro Biopharma Enters Into Collaboration With Pfizer 20
Licensing Agreements 21
EnWave Enters into License Agreement with Sutro Biopharma for powderREV Technology 21
EMD Serono Enters into Licensing Agreement with Sutro Biopharma 22
Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 23
Sutro Biopharma Inc – Key Competitors 24
Sutro Biopharma Inc – Key Employees 25
Sutro Biopharma Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Corporate Communications 27
Mar 09, 2016: Sutro Expands Senior Leadership Team with Addition of Chief Medical Officer and VP of Translational Pharmacology and Preclinical Development 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Sutro Biopharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Sutro Biopharma Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Sutro Biopharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
SutroVax Raises Funds Through Initial Financing Round 10
Sutro Biopharma Raises US$26 Million In Series D Financing 11
Sutro Biopharma Raises US$16.5 Million In Second Tranche Of Series C Financing 13
Sutro Biopharma Amends Co-Development Agreement with Celgene 14
Sutro Biopharma Enters into Agreement with University of California, San Francisco 16
Sutro Biopharma Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 17
Sutro Biopharma Enters Into Co-Development Agreement With Sanofi Pasteur 18
Sutro Biopharma Enters Into Co-Development Agreement With Celgene 19
Sutro Biopharma Enters Into Collaboration With Pfizer 20
EnWave Enters into License Agreement with Sutro Biopharma for powderREV Technology 21
EMD Serono Enters into Licensing Agreement with Sutro Biopharma 22
Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 23
Sutro Biopharma Inc, Key Competitors 24
Sutro Biopharma Inc, Key Employees 25
Sutro Biopharma Inc, Other Locations 26

★海外企業調査レポート[Sutro Biopharma Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cutera Inc (CUTR):製品パイプライン分析
    Summary Cutera Inc (Cutera) is a medical device company that designs, manufactures and markets aesthetic devices. The company provides products that include enlighten, excel V, excel HR, truSculpt, and xeo. Its products are used in treatment of face and body medical aesthetics. Cutera’s enlighten de …
  • CareDx Inc (CDNA):医療機器:M&Aディール及び事業提携情報
    Summary CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used …
  • Agway Energy Services, LLC:企業の戦略的SWOT分析
    Agway Energy Services, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • MTY Food Group Inc.:戦略・SWOT・企業財務分析
    MTY Food Group Inc. - Strategy, SWOT and Corporate Finance Report Summary MTY Food Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Cochlear Ltd (COH):医療機器:M&Aディール及び事業提携情報
    Summary Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions. It develops, manufactures and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage. Its major products include c …
  • Bashneft (BANE):石油・ガス:M&Aディール及び事業提携情報
    Summary Bashneft is a vertically integrated oil and gas company. It operates in the oil and gas production, refining, petrochemical production, marketing and distribution of oil and petroleum products. It sales crude oil, petroleum products and petrochemical products to the domestic market. The comp …
  • AK Steel Holding Corp:企業の戦略・SWOT・財務情報
    AK Steel Holding Corp - Strategy, SWOT and Corporate Finance Report Summary AK Steel Holding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • MolMed SpA (MLM):製薬・医療:M&Aディール及び事業提携情報
    Summary MolMed SpA (Molmed) is a biotechnology company which offers research, development, manufacturing and clinical validation of novel anticancer therapies. Its pipeline antitumour products include Zalmoxis (TK), a cell based therapy enabling bone marrow transplants donors for the treatment of hi …
  • Horizon Therapeutics Plc (HZNP):企業の財務・戦略的SWOT分析
    Horizon Therapeutics Plc (HZNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Legian Beach Hotel:企業の戦略・SWOT・財務分析
    Legian Beach Hotel - Strategy, SWOT and Corporate Finance Report Summary Legian Beach Hotel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Immunomic Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Immunomic Therapeutics Inc (ITI) is a clinical-stage biotechnology company that develops patented lysosomal-associated membrane protein or lamp technology based nucleic acid immunotherapy platforms. The company’s vaccines utilize the body’s natural biochemistry to develop immune response inc …
  • Intrusion Inc (INTZ):企業の財務・戦略的SWOT分析
    Summary Intrusion Inc (Intrusion) is a technology company. The company offers network monitoring and analysis solutions. Its product portfolio includes Savant, TraceCop that enables identification of malicious and illegal activities, Secure Tap a suite of network tap products that enables deployment …
  • Sinclair Oil Corporation:企業の戦略・SWOT・財務分析
    Sinclair Oil Corporation - Strategy, SWOT and Corporate Finance Report Summary Sinclair Oil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pearl Global Industries Limited:企業の戦略・SWOT・財務情報
    Pearl Global Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Pearl Global Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bilfinger Tebodin BV:企業の戦略的SWOT分析
    Bilfinger Tebodin BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • SThree Plc (STHR):企業の財務・戦略的SWOT分析
    Summary SThree Plc (Sthree) is a staffing company that offers permanent and contract staffing business. The company operates through its sectors such as information and communications technology (ICT), energy, engineering, life sciences, banking and finance. Its business brands such as Computer Futu …
  • Tianjin Zhonghuan Semiconductor Co. Ltd. (002129):企業の財務・戦略的SWOT分析
    Tianjin Zhonghuan Semiconductor Co. Ltd. (002129) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Berkshire Hathaway Inc:企業の戦略・SWOT・財務分析
    Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report Summary Berkshire Hathaway Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Sartorius Stedim Biotech SA (DIM):企業の財務・戦略的SWOT分析
    Sartorius Stedim Biotech SA (DIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Tsurumi Manufacturing Co Ltd (6351):企業の財務・戦略的SWOT分析
    Tsurumi Manufacturing Co Ltd (6351) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆